Novonesis (Novozymes) B (OCSE:NSIS B) EBIT per Share : kr13.15 (TTM As of Mar. 2025)

View and export this data going back to 2000. Start your Free Trial

What is Novonesis (Novozymes) B EBIT per Share?

Novonesis (Novozymes) B's EBIT per Share for the three months ended in Mar. 2025 was kr4.39. Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2025 was kr13.15.

During the past 12 months, the average EBIT per Share Growth Rate of Novonesis (Novozymes) B was -26.80% per year. During the past 3 years, the average EBIT per Share Growth Rate was -8.30% per year. During the past 5 years, the average EBIT per Share Growth Rate was 0.40% per year. During the past 10 years, the average EBIT per Share Growth Rate was 1.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Novonesis (Novozymes) B's EBIT per Share or its related term are showing as below:

OCSE:NSIS B' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -8.3 Med: 11.2 Max: 17.2
Current: -8.3

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Novonesis (Novozymes) B was 17.20% per year. The lowest was -8.30% per year. And the median was 11.20% per year.

OCSE:NSIS B's 3-Year EBIT Growth Rate is ranked worse than
57.3% of 1302 companies
in the Chemicals industry
Industry Median: -3.15 vs OCSE:NSIS B: -8.30

Novonesis (Novozymes) B's EBIT for the three months ended in Mar. 2025 was kr2,056 Mil.

Novonesis (Novozymes) B EBIT per Share Historical Data

The historical data trend for Novonesis (Novozymes) B's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novonesis (Novozymes) B EBIT per Share Chart

Novonesis (Novozymes) B Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EBIT per Share

Get a 7-Day Free Trial

12.71

14.37

16.69

14.69

8.01

Novonesis (Novozymes) B Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Dec24	Mar25
EBIT per Share	Get a 7-Day Free Trial															8.43	1.96	1.64	7.12	4.39

Novonesis (Novozymes) B EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Novonesis (Novozymes) B's EBIT per Share for the fiscal year that ended in Dec. 2024 is calculated as

	EBIT per Share		(A: Dec. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	3680.373	/	459.605
=	8.01

Novonesis (Novozymes) B's EBIT per Share for the quarter that ended in Mar. 2025 is calculated as

	EBIT per Share		(Q: Mar. 2025 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	2056.364	/	468.100
=	4.39

EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was kr13.15

Novonesis (Novozymes) B (OCSE:NSIS B) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Novonesis (Novozymes) B EBIT per Share Related Terms

Thank you for viewing the detailed overview of Novonesis (Novozymes) B's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Novonesis (Novozymes) B Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Novonesis (Novozymes) B (OCSE:NSIS B) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

NVZMY:USA NVZMF:USA NSISBc:UK 0Q4U:UK NZM:Germany NZM:Germany NZM2:Germany NZM2:Germany NZYM:Austria

Address

Krogshoejvej 36, Bagsvaerd, DNK, 2880

Website

https://www.novozymes.com

Novonesis was formed in 2024 through the merger of Novozymes and Chr. Hansen. Following the merger, the company became the world leader in industrial enzymes and microbial solutions, with a nearly 50% market share in both. The firm supplies a wide range of industry groups: household care, food and beverages, bioenergy, agriculture and feed, technical and pharmaceuticals. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark, employs around 10,000 people, and works across more than 30 research and development and application centers and 23 manufacturing sites.

Novonesis (Novozymes) B Headlines

No Headlines